Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Samir Gupta MD, MSCS, AGAF

Samir Gupta MD, MSCS, AGAF

Professor of Medicine, Division of Gastroenterology, University of California San Diego; Staff Physician, Jennifer Moreno Department of Veterans Affairs San Diego Healthcare System, San Diego, California

Dr. Gupta is a Professor of Medicine at the University of California San Diego, and Staff Physician at the Jennifer Moreno Department of Veterans Affairs San Diego Healthcare System. His research focuses on the screening and prevention of colorectal cancer. This work has included multiple randomized trials of strategies to boost colorectal cancer screening participation in underserved communities, as well as large scale epidemiologic studies of strategies to prevent cancer after baseline colonoscopy with polypectomy, funded by the National Cancer Institute, Department of Veterans Affairs, and others.  He serves as chair of the National Comprehensive Cancer Network’s annually issued Genetic/Familial High-Risk Assessment: Colorectal guidelines, and led the 2020 US Multisociety Task Force on Colorectal Cancer recommendations for follow up after colonoscopy and polypectomy. Dr. Gupta is an active teacher and mentor, and his medical practice includes performing routine GI procedures, and evaluation and management of individuals at increased risk for GI cancer based on family history and genetic diagnoses.


Dr. Gupta reports the following:
  • Companies developing non-invasive colorectal cancer screening tests:
    • Local site investigator: Epigenomics; Freenome; Exact Sciences
    • Consultant: Guardant Health; Geneoscopy; InterVenn; CellMax Life; Universal Diagnostics